OpenBench

OpenBench, Inc. is a results-oriented molecular discovery company that collaborates with small-molecule biotechnology organizations to enhance preclinical discovery through its proprietary AI virtual screening platform. By providing results-oriented solutions, OpenBench cuts through the noise in AI-driven drug discovery, and partners only pay after molecules are experimentally validated to meet potency and developability criteria.